PRODUCT OVERVIEW & COMPOSITION
Brand / Manufacturer: Bioniche Pharma
Active Ingredients: Nandrolone Decanoate (200 mg per ml) & Testosterone Cypionate (200 mg per ml) — Total Strength: 400 mg/ml
Pharmacological Class: Synthetic Dual-Component Anabolic-Androgenic Steroid Blend ($19\text{-nortestosterone}$ & $17\beta$-cyclopentylpropionate Ester)
This dual-component injectable formulation by Bioniche Pharma combines two potent androgenic and anabolic agents: long-acting Nandrolone Decanoate and Testosterone Cypionate. Formulated by Bioniche Pharma to deliver synergistic tissue-building, erythropoietic, and androgenic support, it restores endogenous androgen deficiency, promotes marked nitrogen retention, and counteracts catabolic tissue depletion when supported by adequate dietary calorie and protein intake.
CLINICAL PHARMACOLOGY & MECHANISM OF ACTION
Androgens and anabolic steroids are responsible for driving cellular protein synthesis, improving nitrogen balance, and stimulating skeletal, muscular, and bone tissue accretion. Bioniche Pharma's combination formulation exerts systemic androgenic effects including the development and maintenance of primary and secondary male sexual characteristics (growth of prostate, seminal vesicles, penis, and scrotum; male pattern hair distribution; laryngeal thickening; and fat distribution shifts). Systemically, this dual formulation promotes cellular nitrogen retention, causes renal conservation of sodium, potassium, and phosphorus, decreases urinary calcium excretion, and enhances basal protein anabolism.
INDICATIONS & CLINICAL USE
- Therapeutic stimulation of lean muscle tissue accretion, cellular restoration, and physical recovery in undernourished, severely debilitated, or underdeveloped patients.
- Adjunctive clinical management of cachexia and muscular atrophy associated with HIV wasting syndrome and other severe catabolic conditions.
- Replacement therapy in severe androgen deficiency requiring concurrent anabolic support under strict medical supervision.
CONTRAINDICATIONS
- Male patients with confirmed or suspected carcinoma of the prostate gland or male breast cancer.
- Female breast carcinoma complicated by severe hypercalcemia (elevated serum calcium levels).
- Patients with severe kidney disease, advanced renal insufficiency, or severe hepatic failure.
- Pregnancy and lactation due to high risks of serious fetal harm, malformation, and endocrine disruption.
- Patients with known hypersensitivity to Nandrolone Decanoate, Testosterone Cypionate, carrier oils, or inactive components in Bioniche Pharma injectables.
PRECAUTIONS & METABOLIC MONITORS
- Glycemic Monitoring: Anabolic steroids can modify insulin sensitivity and systemic glucose tolerance. Diabetic patients undergoing Bioniche Pharma dual-steroid therapy should monitor blood or urine glucose levels frequently, as adjustments to antidiabetic medications may be required.
- Pediatric Caution & Bone Aging: Extreme caution is required if considered for pediatric patients. Androgens may impair sexual development, induce early virilization, and accelerate epiphyseal plate closure, leading to stunted adult stature. Periodic bone age X-rays are mandatory to evaluate effects on skeletal growth.
- Fluid & Electrolyte Balance: Retention of sodium, chloride, water, potassium, and phosphorus may precipitate peripheral edema and blood pressure elevations, requiring careful cardiovascular surveillance.
ADVERSE REACTIONS
- Endocrine & Reproductive: Impotence, testicular atrophy or changes in testicle size, oligospermia, gynecomastia (breast swelling/tenderness), priapism (painful, prolonged erections), and severe pituitary-gonadal axis suppression.
- Dermatological & Androgenic: Severe acne vulgaris, oily skin, accelerated male pattern hair loss (androgenetic alopecia), and body/facial hair shifts.
- Gastrointestinal & Systemic: Diarrhea, sudden weight gain from fluid retention, peripheral swelling, respiratory difficulties/dyspnea, headache, mood alterations, excitation, and sleep disturbances (insomnia).
DOSAGE & ADMINISTRATION
Bioniche Pharma dual-component injectable is formulated strictly for deep intramuscular injection. To maintain stabilized serum androgen levels, administration is recommended 2 times per week:
- Therapeutic Dosage: Typical weekly dosages range between 400 mg and 800 mg (1 ml to 2 ml total weekly volume), adjusted strictly based on individual hormonal status, clinical indication, diagnostic lab findings, and physician supervision.
- Usage Restriction: Not recommended for use in pediatric patients or female individuals due to severe virilization risks.
STORAGE & HANDLING
Store Bioniche Pharma injectable products in a cool, dry place shielded from direct light exposure and excess ambient heat. Do not refrigerate or freeze. Keep strictly out of reach and sight of children.